ANIMAL HEALTH PHARMAS AND BIOTECHS TO ADDRESS STRATEGIES TO CAPITALIZE ON INDUSTRY GROWTH
July 30, 2012 NEW YORK – The animal health industry is poised for incredible growth in the coming decade. Advances in both companion and production animals are driving more profits than ever before and pharma and biotech companies are taking notice
Over 150 biotechs, pharmas, investors, and suppliers will be meeting in Kansas City on November 27-28 at the World Animal Health Congress 2012. Key speakers include Graeme McRae, President, Chairman, and CEO of Bioniche Life Sciences, Michael Oehlsen, International Policy Analyst at the FDA, Marcus Remmers, VP Pharmaceutical R&D of Merial, and Linda Rhodes, CEO of Aratana Therapeutics.
The World Animal Health Congress is the only commercially-focused event specifically for the animal health industry. It is designed to help biotechs successfully develop innovative new products and help pharmas identify the most lucrative companies and technologies currently being developed in the space.
Participants will learn how to:
• Streamline the development process through innovative partnerships
• Identify lucrative unmet needs for companion animals
• Successfully repurpose human drugs for veterinary applications
• Develop strategies for antibiotic use approval from the FDA
To register or learn more visit www.terrapinn.com/animalhealth
About Terrapinn:
Terrapinn is a business media company. Our products are trade exhibitions, conferences, training solutions and electronic and print publications. More information and a schedule of our events can be found at www.terrapinn.com .
CONTACT:
Laura Lupo, Marketing Manager
Terrapinn
laura.lupo@terrapinn.com
+1 646 619 1790
